Hussein M. Ismail

Dr. Hussein M. Ismail

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2015 in Molecular Diagnosis & Therapy
Verified
Journal Article
Closed access
PDF file
Manal S. FawzyManal S. Fawzy
Manal S. Fawzy
OAOsama Alhadramy
Osama Alhadramy
MHMohammad H. Hussein
Mohammad H. Hussein
Hussein M. IsmailHussein M. Ismail
Hussein M. Ismail
NINesreen M. Ismail
Nesreen M. Ismail
ETEman Toraih
Eman Toraih

4 April 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Manal S. FawzyManal S. Fawzy
Manal S. Fawzy
MHMohammad H. Hussein
Mohammad H. Hussein
EAEman Z. Abdelaziz
Eman Z. Abdelaziz
HYHussain A. Yamany
Hussain A. Yamany
Hussein M. IsmailHussein M. Ismail
Hussein M. Ismail
ETEman Toraih
Eman Toraih
Chronic obstructive pulmonary disease (COPD) is a multifactorial chronic respiratory disease, characterized by an obstructive pattern. Understanding the genetic predisposition of COPD is essential to develop personalized treatment regimens. MicroRNAs (miRNAs) are small, endogenous, non-coding RNAs that modulate the expression levels of specific proteins based on sequence complementarity with their target mRNA molecules. Emerging evidences demonstrated the potential use of miRNAs as a disease biomarker. This pilot study aimed to investigate the association of the MIR-196a2 rs11614913 (C/T) polymorphism with COPD susceptibility, the clinical outcome and bronchodilator response to short-acting β2-agonist. Genotyping of rs11614913 polymorphism was determined in 108 COPD male patients and 116 unrelated controls using real-time polymerase chain reaction technology. In silico target prediction and network core analysis were performed. COPD patients did not show significant differences in the genotype distribution (p = 0.415) and allele frequencies (p = 0.306) of the studied miRNA when compared with controls. There were also no associations with GOLD stage, dyspnea grade, disease exacerbations, COPD assessment test for estimating impact on health status score, or the frequency of intensive care unit admission. However, COPD patients with CC genotype corresponded to the smallest bronchodilator response after Salbutamol inhalation, the heterozygotes (CT) had an intermediate response, while those with the TT genotype showed the highest response (p < 0.001). In conclusion MIR-196a2 rs11614913 polymorphism is associated with the bronchodilator response of COPD in our sample of the Egyptian population, generating hypothesis of the potential use of MIR-196a2 variant as a pharmacogenetic marker for COPD.

8 August 2017 in Acta Cardiologica
Verified
Journal Article
Closed access
Manal S. FawzyManal S. Fawzy
Manal S. Fawzy
ETEman Toraih
Eman Toraih
EHElham O. Hamed
Elham O. Hamed
MHMohamed Hussein
Mohamed Hussein
Hussein M. IsmailHussein M. Ismail
Hussein M. Ismail
Background: Circulating microRNAs could be powerful markers of acute myocardial infarction (MI) and its functional genetic variants could increase susceptibility to cardiovascular disease (CVD). The current study aimed to quantify the microRNA (miR)-499a levels in serum of MI patients compared to hypertensive and healthy subjects and to investigate the association of its A/G variant rs3746444 with CVD in a sample of an Egyptian population. Methods: Serum miR-499a relative expressions were measured in 110 acute MI patients, 76 hypertensive patients, and 121 healthy controls by Real-time quantitative polymerase chain reaction. MIR-499a genotyping was performed for an additional 107 coronary artery disease patients by Real-time allele discrimination assay. Results: Acute MI patients showed high relative expression of miR-499a (> 105-fold, p < .001), and it was nearly undetectable in healthy controls and hypertensive patients. It showed an area under the curve of 0.953, with a sensitivity of 97.2% and a specificity of 75.0%. ST-elevation MI (STEMI) patients had higher miR-499a serum levels than patients with Non-STEMI. There was a significant association of MIR-499a variant with acute MI but not with hypertension under all genetic models tested. As a new finding, in overall and stratified analysis, the miR-499a variant was not correlated with its expression profile. Conclusions: Circulating miR-499a levels could be a useful biomarker, discriminating acute MI within 12 hours from healthy subjects. Its variant rs3746444 A/G is associated with increased susceptibility to acute MI and CAD in Egyptian population.

1 August 2016 in Journal of Taibah University Medical Sciences
Verified
Journal Article
Open access
MAMansour M. Al-Nozha
Mansour M. Al-Nozha
Hussein M. IsmailHussein M. Ismail
Hussein M. Ismail
ONOmar M. Al Nozha
Omar M. Al Nozha
ObjectivesDiabetes mellitus (DM) and coronary artery disease (CAD) are closely related. DM is a risk factor for CAD, but it is also equivalent to established CAD. The prevalence of DM and CAD is growing primarily due to the rising prevalence of obesity. The rapidly changing life style, especially in developing countries, plays major role in the occurrence of these diseases.MethodsWe performed a literature review to summarize and explore the relationship between CAD and DM with a special focus on Arab countries in terms of risk factors and prevalence. We suggest future directions to prevent escalation in the incidence of DM and CAD in Arab countries.ConclusionAn important part of any preventive program for CAD should include clear prevention strategies for DM and other associated metabolic risk factors, such as obesity. Preventive measures, such as physical exercise in high-risk groups, at the population level should be encouraged

22 May 2012 in Journal of Interventional Cardiology
Verified
Journal Article
Closed access
PDF file
MBMohammed Elshawadfy M. Bilasy
Mohammed Elshawadfy M. Bilasy
MOMohammed A. Oraby
Mohammed A. Oraby
Hussein M. IsmailHussein M. Ismail
Hussein M. Ismail
FMFathi A. Maklady
Fathi A. Maklady

1 August 2021 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
Hussein M. IsmailHussein M. Ismail
Hussein M. Ismail
AAAbeer S Algrafi
Abeer S Algrafi
OAOsama Amoudi
Osama Amoudi
SASameh Ahmed
Sameh Ahmed
STSultan S Al Thagfan
Sultan S Al Thagfan
AAAyat R Abdallah
Ayat R Abdallah
Background: Vitamin D deficiency is considered an emerging health problem that affects at least one billion patients worldwide. Calcitriol 1,25(OH)2D3 has several systemic effects, including anti-inflammatory, anti-thrombotic and anti-atherosclerotic impacts that explain its cardioprotective effects. The precise association between vitamin D and its metabolites and the value of supplements in acute coronary syndrome (ACS) is still controversial. This study aims to search the association between vitamin D2, D3, and metabolites and ACS in patients undergoing coronary angiography. Materials and Methods: This was a case–control study on 73 consecutive adult patients with ACS undergoing coronary angiography compared to 50 controls without coronary artery disease and matched for age and sex from June 2019 till July 2019. Echocardiography and coronary angiography were done for all cases. Plasma vitamin D and its metabolites were measured at admission for all participants along with chemistry profiles. Results: Vitamin D and its metabolites were statistically significantly lower in ACS patients than the controls. Multivariate regression analysis revealed that low levels of 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D) significantly predicted ACS occurrence; the other significant predictors were high systolic blood pressure (BP), high total cholesterol, and low high-density lipoprotein-cholesterol. Interestingly, vitamin D2 and D3 did not significantly predict ACS (p> 0.05). We did not find a statistically significant association between the number of affected coronary vessels and vitamin D metabolites. Moreover, there was no statistically significant correlation between vitamin D and its metabolites and left ventricular ejection fraction measured by echocardiography. Conclusion: There was a strong association between vitamin D and all its metabolites with ACS. Significantly, low 25(OH)D and 1,25(OH)2D predicted ACS, but vitamin D2 and D3 did not. Large randomized controlled trials are needed to verify the beneficial values of vitamin D supplementation in ACS patients.